HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,631 | +2.8% | 16,116 | -2.9% | 0.02% | +5.0% |
| Q2 2023 | $598,618 | -5.3% | 16,596 | +0.3% | 0.02% | -4.8% |
| Q1 2023 | $631,853 | +40586.0% | 16,545 | -39.4% | 0.02% | -62.5% |
| Q4 2022 | $1,553 | -99.9% | 27,285 | -14.6% | 0.06% | +14.3% |
| Q3 2022 | $1,263,000 | +0.7% | 31,955 | +12.1% | 0.05% | +8.9% |
| Q2 2022 | $1,254,000 | +130.9% | 28,505 | +109.3% | 0.04% | +164.7% |
| Q1 2022 | $543,000 | -0.9% | 13,620 | 0.0% | 0.02% | +6.2% |
| Q4 2021 | $548,000 | -1.1% | 13,620 | 0.0% | 0.02% | -30.4% |
| Q3 2021 | $554,000 | – | 13,620 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |